New type of injection marker visible under CT, MRI, and ultrasound for FDA access

Release date: 2013-02-20

Recently, Augmenix's TraceIT Tissue Marker received FDA access. This marker is very useful in medical imaging because it is visible under CT\MRI\cone beam CT and ultrasound. It remains stable in the body for up to 3 months and is then absorbed by the body and excreted.
This new marker helps clinicians to more accurately fuse MRI\CT images and better utilize cone beam CT during radiotherapy. According to the statement, TraceIT is a synthetic hydrogel that primarily crosslinks polyethylene glycol with water and iodate. After injection through a fine needle, a small amount of hydrogel injection in the lungs, breast, prostate and other tissues is clearly visible. The gel's stability for three months is sufficient for radiation therapy and then absorbed by the body. discharge.
According to Patrick Kupelian, a professor of radiation oncology at the University of California, Los Angeles, "When applying tumor markers, other commercial markers always produce persistent image artifacts in the region of interest, and the use of this absorbable hydrogel This will not cause the above problems.

Source: Kexun

Medical High-polymer Tube Products

Nebuliser Mask,Nebulizer Mask ,Laryngeal Mask Airway,Nebulizer Mask And Tubing

Surgimed Medical Supplies Co.,Ltd , https://www.surgimedcn.com